Zenflow Overview
- Year Founded
-
2014
- Status
-
Private
- Employees
-
47
- Latest Deal Type
-
2ndary - Private
- Investors
-
15
Zenflow General Information
Description
Developer of a medical device platform designed to improve urologic care for men with benign prostatic hyperplasia symptoms. The company offers an implant and delivery system with patient-focused design and minimally invasive treatment capabilities, enabling men with benign prostatic hyperplasia to receive symptom relief with an improved treatment experience.
Contact Information
Website
www.zenflow.comCorporate Office
- 395 Oyster Point Boulevard
- Suite 501
- South San Francisco, CA 94080
- United States
Corporate Office
- 395 Oyster Point Boulevard
- Suite 501
- South San Francisco, CA 94080
- United States
Zenflow Timeline
Zenflow Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 20. Secondary Transaction - Private | Completed | Generating Revenue | ||||
| 19. Later Stage VC (Series D) | 05-Oct-2026 | Completed | Generating Revenue | |||
| 18. Later Stage VC (Series C) | 05-Nov-2025 | Completed | Generating Revenue | |||
| 17. Later Stage VC (Series C) | 01-Nov-2024 | Completed | Generating Revenue | |||
| 16. Accelerator/Incubator | 09-Jun-2022 | Completed | Generating Revenue | |||
| 15. Secondary Transaction - Private | Completed | Pre-Clinical Trials | ||||
| 14. Later Stage VC (Series B) | 19-May-2021 | Completed | Pre-Clinical Trials | |||
| 13. Grant | 15-Sep-2019 | Completed | Pre-Clinical Trials | |||
| 12. Debt - General | 27-Nov-2018 | $5M | $40.3M | Completed | Pre-Clinical Trials | |
| 11. Early Stage VC (Series A) | 08-Dec-2017 | $31.5M | $35.3M | Completed | Pre-Clinical Trials |
Zenflow Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate ($) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series C-1 | ||||||||
| Series C | ||||||||
| Series B | ||||||||
| Series A3 | ||||||||
| Series A2 | ||||||||
| Series A1 | 78,740 | $0.1 | $1.27 | $1.27 | 1x | $1.27 | 0.09% | |
| Series A | 16,706,742 | $0.13 | $1.68 | $1.68 | 1x | $1.68 | 18.38% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
Zenflow Comparisons
Industry
Financing
Details
Zenflow Competitors (6)
One of Zenflow’s 6 competitors is UroLift, a Corporation company based in Pleasanton, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| UroLift | Corporation | Pleasanton, CA | ||||
| Urologix | Formerly VC-backed | Minneapolis, MN | ||||
| Butterfly Medical | Venture Capital-Backed | Yokneam, Israel | ||||
| iTind | Formerly VC-backed | Hadera, Israel | ||||
| ProVerum | Venture Capital-Backed | Dublin, Ireland |
Zenflow Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Zenflow Patents
Zenflow Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2021356654-A1 | Systems, devices, and methods for the retrieval of an implant in the prostatic urethra | Pending | 08-Oct-2020 | ||
| CA-3194788-A1 | Systems, devices, and methods for the retrieval of an implant in the prostatic urethra | Pending | 08-Oct-2020 | ||
| EP-4225225-A1 | Systems, devices, and methods for the retrieval of an implant in the prostatic urethra | Pending | 08-Oct-2020 | ||
| EP-4225225-A4 | Systems, devices, and methods for the retrieval of an implant in the prostatic urethra | Pending | 08-Oct-2020 | ||
| US-12414850-B2 | Systems, devices, and methods for the retrieval of an implant in the prostatic urethra | Active | 08-Oct-2020 | A61F2/04 |
Zenflow Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Zenflow Investors (15)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| ClavystBio | Venture Capital | Minority | ||
| Cook Medical | PE-Backed Company | Minority | ||
| Brightway Future Capital | Venture Capital | Minority | ||
| Golden Seeds | Venture Capital | Minority | ||
| Invus Opportunities | Venture Capital | Minority |
Zenflow FAQs
-
When was Zenflow founded?
Zenflow was founded in 2014.
-
Where is Zenflow headquartered?
Zenflow is headquartered in South San Francisco, CA.
-
What is the size of Zenflow?
Zenflow has 47 total employees.
-
What industry is Zenflow in?
Zenflow’s primary industry is Therapeutic Devices.
-
Is Zenflow a private or public company?
Zenflow is a Private company.
-
What is Zenflow’s current revenue?
The current revenue for Zenflow is .
-
How much funding has Zenflow raised over time?
Zenflow has raised $145M.
-
Who are Zenflow’s investors?
ClavystBio, Cook Medical, Brightway Future Capital, Golden Seeds, and Invus Opportunities are 5 of 15 investors who have invested in Zenflow.
-
Who are Zenflow’s competitors?
UroLift, Urologix, Butterfly Medical, iTind, and ProVerum are some of the 6 competitors of Zenflow.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
